Valerie Start
Förmögenhet: 393 360 $ per 2026-08-31
Förmögenhet: 393 360 $ per 2026-08-31
Valerie Denise Harding Start is currently an Independent Director at Erasca, Inc. since 2019, a Member & Partner at Smallify LLC, and Principal at Start Pharma Consulting LLC since 2019.
Formerly, Dr. Start was Vice President-Product Differentiation at Pfizer Inc. in 2012 and Senior VP-Chemistry, Manufacturing & Controls at Ignyta, Inc. from 2015 to 2019.
Dr. Start completed undergraduate studies at the University of London and earned a doctorate from The University of Nottingham.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ERASCA, INC. 0,01 % | 2026-06-26 | 22 000 ( 0,01 % ) | 393 360 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ERASCA, INC. | Direktör/Styrelseledamot | 2019-06-01 |
Start Pharma Consulting LLC | Företagsledare/Principal | 2019-02-01 |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| IGNYTA INC | Företagsledare/Principal | 2019-01-01 |
| PFIZER INC. | Företagsledare/Principal | 2012-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Commercial Services |
Start Pharma Consulting LLC |
Välj din utgåva
All finansiell information anpassad till den nationella nivån